Ocular Therapeutix Inc.

NASDAQ: OCUL · Real-Time Price · USD
12.43
-0.19 (-1.51%)
At close: Aug 18, 2025, 10:44 AM

Ocular Therapeutix Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-193.51M -80.74M -71.04M -6.55M
Depreciation & Amortization
3.79M 2.98M 2.11M 2.42M
Stock-Based Compensation
33.11M 17.82M 16.96M 14.98M
Other Working Capital
-2.97M -2.81M 2.88M 4.24M
Other Non-Cash Items
21.93M -2.9M -8.99M 4.63M
Deferred Income Tax
n/a n/a n/a -78.12M
Change in Working Capital
n/a -7.41M 1.35M -2.9M
Operating Cash Flow
-134.68M -70.23M -59.6M -65.55M
Capital Expenditures
-1.29M -6.09M -3.71M -1.19M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -3.71M n/a
Investing Cash Flow
-1.29M -6.09M -3.71M -1.19M
Debt Repayment
n/a 56.35M n/a -445K
Common Stock Repurchased
n/a n/a n/a 985K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
15.76M -3.78M 1.45M 3.3M
Financial Cash Flow
332.11M 169.83M 1.45M 2.85M
Net Cash Flow
196.15M 93.51M -61.86M -63.89M
Free Cash Flow
-135.97M -76.32M -63.32M -66.74M